NCT02367352View on ClinicalTrials.gov

Alisertib (MLN8237) in Combination With Weekly Paclitaxel in East Asian Patients With Advanced Solid Tumors

PHASE1TerminatedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

March 19, 2015

Primary Completion Date

May 23, 2017

Study Completion Date

May 23, 2017

Conditions
Advanced Solid TumorsOvarian CancerSmall Cell Lung Cancer
Interventions
DRUG

Alisertib

Alisertib tablets

DRUG

Paclitaxel

Paclitaxel intravenous solution

Trial Locations (3)

Unknown

Chiba

Shizuoka

Seoul

Sponsors
All Listed Sponsors
lead

Millennium Pharmaceuticals, Inc.

INDUSTRY